Unibest
← Back to patent-cliff list

CAS 937273-31-9

2-((allyloxy)methyl)-1-(2-chloroethoxy)-4-nitrobenzene

Codes: PACR-006

Application context (from source-drug indications)

MyelofibrosisPacritinib CitrateThrombocytopeniaPacritinib CitrateAcute myeloid leukaemiaPacritinib CitrateEssential thrombocythaemiaPacritinib CitratePolycythaemia veraPacritinib CitrateChronic myelomonocytic leukaemiaPacritinib Citrate

Source drugs (routes using this intermediate)

DrugTierExpiry
Pacritinib CitrateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works2-((allyloxy)Methyl)-1-(2-chl oroethoxy)-4-nitrob
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.